
Join to View Full Profile
1 Childrens Pl# DivSt. Louis, MO 63110
Phone+1 314-454-2694
Fax+1 314-454-2515
Dr. Polineni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2010
University of MichiganResidency, Internal Medicine, 2004 - 2007
University of Missouri Kansas City School of MedicineClass of 2004
Certifications & Licensure
MO State Medical License 2022 - 2026
KS State Medical License 2013 - 2023
NC State Medical License 2008 - 2014
MI State Medical License 2004 - 2007
American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Tele-Coaching Intervention to Improve Treatment Adherence in Cystic Fibrosis Start of enrollment: 2020 Jan 13
Publications & Presentations
PubMed
- 4 citationsPartners in research: The success with therapies research consortium and the CF community unite to improve self-management.Gregory S Sawicki, Andrea Goodman, Callie Bacon, Lauren Collins, Jonathan Greenberg
Journal of Cystic Fibrosis. 2023-09-01 - 6 citationsTrabecular bone score in people with cystic fibrosis.A Anabtawi, M Holyoak, J He, E Cristiano, D Polineni
Osteoporosis International. 2022-05-01 - 171 citationsTriple Therapy for Cystic Fibrosis Phe508del -Gating and -Residual Function Genotypes.Peter J. Barry, Marcus A. Mall, Antonio Álvarez, Carla Colombo, Karin M. de Winter-de Groot
The New England Journal of Medicine. 2021-08-25
Press Mentions
KU Health System Launching Clinical Study Using Cancer Drug Against COVID-19August 14th, 2020
KU Researchers Pivot from Cancer and Cystic Fibrosis to Test New Drug for COVID-19August 14th, 2020
Researchers Pivot from Studying Cancer and Cystic Fibrosis to Launch Trial of Drug to Fight COVID-19August 13th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









